The threat of antimicrobial resistance in developing countries: causes and control strategies

被引:781
作者
Ayukekbong, James A. [1 ,4 ]
Ntemgwa, Michel [2 ]
Atabe, Andrew N. [3 ]
机构
[1] Redeem Biomed, Sect Clin Microbiol, POB 16, Buea, Cameroon
[2] Hlth Canada, Human Safety Div, Hlth Prod & Food Branch, Vet Drugs Directorate, Ottawa, ON, Canada
[3] Univ Ottawa, Fac Med, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada
[4] Metabiota Inc, Nanaimo, BC, Canada
来源
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL | 2017年 / 6卷
关键词
Antimicrobial therapy; Developing countries; Microorganisms; Resistance; ANTIBIOTIC-RESISTANCE; RETAIL PHARMACIES; GROWING PROBLEM; RISK-FACTORS; DRUGS; DISEASE; THERAPY; IMPACT; KENYA; CARE;
D O I
10.1186/s13756-017-0208-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The causes of antimicrobial resistance (AMR) in developing countries are complex and may be rooted in practices of health care professionals and patients' behavior towards the use of antimicrobials as well as supply chains of antimicrobials in the population. Some of these factors may include inappropriate prescription practices, inadequate patient education, limited diagnostic facilities, unauthorized sale of antimicrobials, lack of appropriate functioning drug regulatory mechanisms, and non-human use of antimicrobials such as in animal production. Considering that these factors in developing countries may vary from those in developed countries, intervention efforts in developing countries need to address the context and focus on the root causes specific to this part of the world. Here, we describe these health-seeking behaviors that lead to the threat of AMR and healthcare practices that drive the development of AMR in developing countries and we discuss alternatives for disease prevention as well as other treatment options worth exploring.
引用
收藏
页数:8
相关论文
共 73 条
[1]   Get pigs off antibiotics [J].
Aarestrup, Frank .
NATURE, 2012, 486 (7404) :465-466
[2]  
ADDIS Z, 2011, BMC INFECT DIS, V11
[3]  
Africa Society for Laboratory Medicine, 2016, ASLM2016 HELPS ANSW
[4]   Bacteriophages show promise as antimicrobial agents [J].
Alisky, J ;
Iczkowski, K ;
Rapoport, A ;
Troitsky, N .
JOURNAL OF INFECTION, 1998, 36 (01) :5-15
[5]   Bacteriophage therapy and prophylaxis: Rediscovery and renewed assessment of potential [J].
Barrow, PA ;
Soothill, JS .
TRENDS IN MICROBIOLOGY, 1997, 5 (07) :268-271
[6]   Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication [J].
Basco, LK .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2004, 70 (03) :245-250
[7]   Assessing the impact of a regulatory intervention in Pakistan [J].
Bhutta, TI ;
Balchin, C .
SOCIAL SCIENCE & MEDICINE, 1996, 42 (08) :1195-1202
[8]   Infectious diseases physicians' preferences for continuing medical education on antimicrobial resistance and other general topics [J].
Blakely, Jennifer Tuboku-Metzger ;
Sinkowitz-Cochran, Ronda L. ;
Jarvis, William R. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (08) :873-875
[9]   Fecal microbiota transplantation: Indications, methods, evidence, and future directions [J].
Borody T.J. ;
Paramsothy S. ;
Agrawal G. .
Current Gastroenterology Reports, 2013, 15 (8)
[10]  
Borody TJ, 2013, EXPERT REV ANTI-INFE, V11, P447, DOI [10.1586/ERI.13.26, 10.1586/eri.13.26]